| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/01/2009 | US7582633 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them |
| 09/01/2009 | US7582366 Difluoropyridine-based compound and organic electroluminescent device using the same |
| 09/01/2009 | US7582273 Preparation of carbon nanoparticles and carbon nitride from high nitrogen compound |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
| 08/27/2009 | WO2009105715A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105604A1 Substituted triazolopyridines |
| 08/27/2009 | WO2009105500A1 Compounds that are erk inhibitors |
| 08/27/2009 | WO2009105206A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/27/2009 | WO2009104708A1 Polymer compound and organic electroluminescent device using the same |
| 08/27/2009 | WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives |
| 08/27/2009 | WO2009104021A2 Novel polymorphs and processes for their preparation |
| 08/27/2009 | WO2009103652A1 Modulators for amyloid beta |
| 08/27/2009 | WO2009103432A2 Covalently binding imaging probes |
| 08/27/2009 | WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
| 08/27/2009 | WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 08/27/2009 | WO2009080226A3 Heterocyclic pyrazole-carboxamides as p2y12 antagonists |
| 08/27/2009 | WO2009067674A3 Polymorphs of sunitinib base and processes for preparation thereof |
| 08/27/2009 | WO2009026248A3 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase |
| 08/27/2009 | US20090216026 Novel synthesis of irbesartan |
| 08/27/2009 | US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/27/2009 | US20090215803 Pyrimidinones as Casein Kinase II (CK2) Modulators |
| 08/27/2009 | US20090215799 Heterocyclic substituted bisarylurea derivatives |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215772 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 08/27/2009 | US20090215770 Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases |
| 08/27/2009 | US20090215759 Modulators for amyloid beta |
| 08/27/2009 | US20090215756 Formulations containing losartan and/or its salts |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215712 Pyrazole derivatives |
| 08/27/2009 | US20090214465 Quinoxaline Derivatives as Antitumor Agents |
| 08/27/2009 | US20090211038 Hemicyanin styryl thiol/disulfide dye, composition comprising hemicyanin styryl thiol/disulfide dye, and method for lightening keratin materials using hemicyanin styryl thiol/disulfide dye |
| 08/27/2009 | CA2715657A1 Novel polymorphs and processes for their preparation |
| 08/27/2009 | CA2714743A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
| 08/27/2009 | CA2714703A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2714479A1 Compounds that are erk inhibitors |
| 08/27/2009 | CA2714122A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/27/2009 | CA2713716A1 Modulators for amyloid beta |
| 08/27/2009 | CA2713184A1 2-aza-bicyclo[2.2.1]heptane derivatives |
| 08/26/2009 | EP2093225A1 Process for preparing crystalline eletriptan hydrobromide form ß |
| 08/26/2009 | EP2093224A1 Process for preparing eletriptan hydrobromide form beta |
| 08/26/2009 | EP2092824A1 Heterocyclyl pyrimidines |
| 08/26/2009 | EP2091945A1 Novel inhibitors of glutaminyl cyclase |
| 08/26/2009 | EP2091941A2 Mapk/erk kinase inhibitors |
| 08/26/2009 | EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 08/26/2009 | EP2091937A2 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 08/26/2009 | EP2091926A1 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 08/26/2009 | EP2091924A1 Pyrimidine derivatives and their use as pesticides |
| 08/26/2009 | EP2091922A2 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 08/26/2009 | EP1904484B1 Compounds |
| 08/26/2009 | EP1783116B1 2-phenylpyridine derivative |
| 08/26/2009 | EP1773817B1 Substituted aryl-amine derivatives and methods of use |
| 08/26/2009 | EP1745033A4 4,5-disubstituted-2-aryl pyrimidines |
| 08/26/2009 | EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 08/26/2009 | CN101516874A Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 08/26/2009 | CN101516873A Indazolyl derivatives useful as potassium channel modulating agents |
| 08/26/2009 | CN101516871A Novel pyridazine derivatives |
| 08/26/2009 | CN101516868A Novel pyridazine derivatives |
| 08/26/2009 | CN101516867A Aryl sulfonamides with an analgesic action |
| 08/26/2009 | CN101516864A Process for the preparation of candesartan cilexetil form I |
| 08/26/2009 | CN101516856A Heterocyclic bridged biphenyls and their use in oleds |
| 08/26/2009 | CN101516852A Quinoline derivatives with 5-HT-binding properties |
| 08/26/2009 | CN101516850A Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 08/26/2009 | CN101516844A 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 08/26/2009 | CN101514191A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 08/26/2009 | CN101513402A Antiviral agent |
| 08/26/2009 | CN100532380C Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient |
| 08/26/2009 | CN100532378C Light-sensitive luminous europium complex and light-sensitive ligand molecule and their synthesizing method |
| 08/26/2009 | CN100532377C Compound containing tetrazine polynitrobenzene and synthesis method thereof |
| 08/25/2009 | US7579466 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 08/25/2009 | US7579465 For treatment of picornavirus infections in mammals |
| 08/25/2009 | US7579352 Retinoic acid mimetic anilides |
| 08/25/2009 | US7579350 Scaffolds for α-helix mimicry |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579339 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 08/25/2009 | CA2538072C Amide-type carboxamide derivatives |
| 08/25/2009 | CA2474578C Novel pyridin- and pyrimidin-derivatives |
| 08/25/2009 | CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2327673C Aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| 08/20/2009 | WO2009103022A1 Derivatives of substituted fused ring cycloindoles and methods of their use |
| 08/20/2009 | WO2009102694A1 Heterocyclic derivatives as hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102633A1 Hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102568A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102325A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102318A1 Hepatitis c virus inhibitors |
| 08/20/2009 | WO2009101079A1 Pyrimidylmethyl sulfonamide compounds |
| 08/20/2009 | WO2009101078A1 Pyrimidylmethyl sulfonamide compounds |
| 08/20/2009 | WO2009101018A2 3-alkyl-piperazine derivatives and uses thereof |
| 08/20/2009 | WO2009100929A1 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide |
| 08/20/2009 | WO2009081105A3 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 08/20/2009 | WO2009055721A3 5-lipoxygenase activating protein (flap) inhibitor |
| 08/20/2009 | WO2009037244A3 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 08/20/2009 | US20090209565 Therapeutic agent for inflammatory bowel disease |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209556 Soluble guanylate cyclase activators |
| 08/20/2009 | US20090209555 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 08/20/2009 | US20090209553 Arylpiperazine derivatives and uses thereof |
| 08/20/2009 | US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |